These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 29421807)

  • 1. The Clinical Management of Main Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas.
    Dal Borgo C; Perri G; Borin A; Marchegiani G; Salvia R; Bassi C
    Dig Surg; 2019; 36(2):104-110. PubMed ID: 29421807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of main pancreatic duct dilatation in IPMN undergoing surveillance.
    Marchegiani G; Andrianello S; Morbin G; Secchettin E; D'Onofrio M; De Robertis R; Malleo G; Bassi C; Salvia R
    Br J Surg; 2018 Dec; 105(13):1825-1834. PubMed ID: 30106195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
    Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical overtreatment of pancreatic intraductal papillary mucinous neoplasms: Do the 2017 International Consensus Guidelines improve clinical decision making?
    Sharib JM; Fonseca AL; Swords DS; Jaradeh K; Bracci PM; Firpo MA; Hatcher S; Scaife CL; Wang H; Kim GE; Mulvihill SJ; Maitra A; Koay EJ; Kirkwood KS
    Surgery; 2018 Dec; 164(6):1178-1184. PubMed ID: 30170819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intraductal papillary mucinous neoplasm of pancreas].
    Panteleev VI; Gorin DS; Kaldarov AR; Kriger AG
    Khirurgiia (Mosk); 2019; (11):81-87. PubMed ID: 31714535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
    Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
    Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
    Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraductal papillary mucinous neoplasms of the pancreas.
    Gourgiotis S; Ridolfini MP; Germanos S
    Eur J Surg Oncol; 2007 Aug; 33(6):678-84. PubMed ID: 17207960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proper management and follow-up strategy of branch duct intraductal papillary mucinous neoplasms of the pancreas.
    Bae SY; Lee KT; Lee JH; Lee JK; Lee KH; Rhee JC
    Dig Liver Dis; 2012 Mar; 44(3):257-60. PubMed ID: 22030480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CD117, CK17, CK20, MUC4, villin and mismatch repair deficiency in pancreatic intraductal papillary mucinous neoplasm.
    Detlefsen S; Jakobsen M; Nielsen MFB; Klöppel G; Mortensen MB
    Pathol Res Pract; 2021 Jan; 217():153312. PubMed ID: 33341087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraductal Papillary Mucinous Neoplasm of the Pancreas.
    Fong ZV; Fernández-Del Castillo C
    Surg Clin North Am; 2016 Dec; 96(6):1431-1445. PubMed ID: 27865286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonoperative management of main pancreatic duct-involved intraductal papillary mucinous neoplasm might be indicated in select patients.
    Roch AM; DeWitt JM; Al-Haddad MA; Schmidt CM; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    J Am Coll Surg; 2014 Jul; 219(1):122-9. PubMed ID: 24862887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas.
    Fritz S; Schirren M; Klauss M; Bergmann F; Hackert T; Hartwig W; Strobel O; Grenacher L; Büchler MW; Werner J
    Surgery; 2012 Sep; 152(3 Suppl 1):S74-80. PubMed ID: 22770954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enucleation: A treatment alternative for branch duct intraductal papillary mucinous neoplasms.
    Kaiser J; Fritz S; Klauss M; Bergmann F; Hinz U; Strobel O; Schneider L; Büchler MW; Hackert T
    Surgery; 2017 Mar; 161(3):602-610. PubMed ID: 27884612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules.
    Sadakari Y; Ienaga J; Kobayashi K; Miyasaka Y; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    Pancreas; 2010 Mar; 39(2):232-6. PubMed ID: 19752768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative pancreatoscopy in pancreaticoduodenectomy for intraductal papillary mucinous neoplasms of the pancreas: Application to the laparoscopic approach.
    Yang HY; Kang I; Hwang HK; Lee WJ; Kang CM
    Asian J Surg; 2023 Jan; 46(1):166-173. PubMed ID: 35331591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic-duct-lavage cytology in candidates for surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas: should the International Consensus Guidelines be revised?
    Sai JK; Suyama M; Kubokawa Y; Watanabe S; Maehara T
    Gastrointest Endosc; 2009 Mar; 69(3 Pt 1):434-40. PubMed ID: 18684453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
    Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
    Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review of the utility of 18-FDG PET in the preoperative evaluation of IPMNs and cystic lesions of the pancreas.
    Srinivasan N; Koh YX; Goh BKP
    Surgery; 2019 May; 165(5):929-937. PubMed ID: 30577952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic intraductal papillary mucinous neoplasm--where is the challenge?
    Fritz S; Hackert T; Büchler MW
    Dig Dis; 2015; 33(1):99-105. PubMed ID: 25531503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.